The Cambridge-based drug maker said the deal settles "all worldwide" litigation related to certain drugs and it won't have to pay royalties to other companies.

Moderna shares rose 10% in premarket trading on Wednesday after the company settled a long-running legal battle over the technology that made its COVID-19 vaccine possible, ...

In 2024, the U.S. Equal Employment Opportunity Commission (EEOC) sued Rex Healthcare on behalf of an employee fired for ...

Questions about the COVID-19 shot abound as federal recommendations shift and medical groups issue clashing guidance.

Feb 26 (Reuters) - ⁠The ⁠U.S. CDC's ⁠vaccine advisory committee will ​discuss and may ‌vote on recommendations ‌for issues ...

Earlier this month, major U.S. medical groups asked a federal judge to block the administration from implementing new guidance that cuts the number of vaccines routinely recommended for children and ...

COVID-19 vaccinations were shown to reduce virus-related hospitalizations and severe disease-associated outcomes in immunocompetent adults. The findings from a recently published JAMA Network Open ...

COVID-19 vaccination showed effectiveness in reducing hospitalizations and severe disease outcomes associated with the SARS-CoV-2 JN.1 lineage, according to a recent study published in JAMA Network ...

The Centers for Disease Control and Prevention’s influential vaccine advisory panel will consider issuing recommendations ...

Researchers at University of California San Diego School of Medicine have found that a natural fungal supplement taken at the ...

Federal investment in RNA vaccine research has supported nearly three decades of scientific work spanning infectious diseases, cancer, and vaccine development, but recent and proposed funding cuts ...